Covered recipient · General Payments record
ALEXANDRIA CALDWELL
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$841.40
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $144.16 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Dynavax Technologies Corporation | $40.14 | 2 |
| Medtronic, Inc. | $21.27 | 1 |
| Mylan Specialty L.P. | $20.64 | 1 |
| Acerta Pharma LLC | $19.54 | 1 |
| Sumitomo Pharma America, Inc. | $14.98 | 1 |
| Novo Nordisk AS | $14.51 | 1 |
| GlaxoSmithKline, LLC. | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $19.54 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104430675 | CMS |
| Dynavax Technologies Corporation | $20.66 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082144617 | CMS |
| Dynavax Technologies Corporation | $19.48 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082150199 | CMS |
| GlaxoSmithKline, LLC. | $13.08 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116578002 | CMS |
| Medtronic, Inc. | $21.27 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119576163 | CMS |
| Mylan Specialty L.P. | $20.64 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147333223 | CMS |
| Novo Nordisk Inc | $14.51 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096605689 | CMS |
| Sumitomo Pharma America, Inc. | $14.98 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148834413 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.